ARQL

ArQule, Inc. News Headlines

$1.1901
*  
0.0401
3.49%
Get ARQL Alerts
*Delayed - data as of Dec. 18, 2014 15:47 ET  -  Find a broker to begin trading ARQL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARQL After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
PTC Therapeutics, Inc. (PTCT) in Focus: Stock Gains 5.2% - Tale of the Tape
12/10/2014 9:32:00 AM - Zacks.com


Zacks Rank #1 Additions for Thursday - Tale of the Tape
12/4/2014 9:30:00 AM - Zacks.com


Can the Uptrend Continue for ArQule (ARQL)? - Tale of the Tape
11/28/2014 6:36:24 AM - Zacks.com


ArQule (ARQL) Shows Strength: Stock Adds 6% in Session - Tale of the Tape
11/18/2014 9:39:00 AM - Zacks.com


Zacks Rank #1 Additions for Tuesday - Tale of the Tape
11/18/2014 9:30:00 AM - Zacks.com


Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog
11/13/2014 4:30:00 PM - Zacks.com


ArQule (ARQL) Catches Eye: Stock Jumps 10.4% - Tale of the Tape
11/11/2014 8:30:00 AM - Zacks.com


Sector Update: Health Care Stocks Pacing Market Gains; ArQule Rising After Experimental Cancer Drug Posts Positive Trial Results
11/10/2014 1:25:45 PM - MT Newswires


Sector Update: Health Care
11/10/2014 1:24:01 PM - MT Newswires


ArQule Reports Positive Top-Line Results Of Phase 2 Trial Of Tivantinib
11/10/2014 8:17:00 AM - RTT News


ArQule Q3 14 Earnings Conference Call At 9:00 AM ET
11/10/2014 8:00:00 AM - RTT News


ArQule Inc. (ARQL) in Focus: Stock Rises 8.21% - Tale of the Tape
5/30/2014 7:44:00 AM - Zacks.com


ArQule Posts Narrower-than-Expected Q1 Loss - Analyst Blog
5/8/2014 12:58:00 PM - Zacks.com


ArQule's Loss Narrows in Q4 - Analyst Blog
3/6/2014 1:37:01 PM - Zacks.com


A Close Look At ArQule
2/8/2014 3:20:00 PM - Seeking Alpha


Data on ArQule's Tivantinib - Analyst Blog
2/5/2014 5:40:01 PM - Zacks.com


ArQule Up on Study Results - Analyst Blog
1/17/2014 6:04:01 PM - Zacks.com


Healthcare Stocks Declining; ArQule Jumps After Data Committee Signs Off On Continued Study of Cancer Medication
1/17/2014 3:58:05 PM - MT Newswires


Sector Update: Healthcare
1/17/2014 3:57:13 PM - MT Newswires


RedHill Biopharma Sells ADS - Analyst Blog
12/31/2013 6:09:01 PM - Zacks.com


Zacks #1 Rank Additions for Tuesday - Tale of the Tape
12/31/2013 9:30:01 AM - Zacks.com


ArQule, Inc. Enters Oversold Territory - Tale of the Tape
12/18/2013 8:34:51 AM - Zacks.com


Narrower-than-Expected Loss at ArQule - Analyst Blog
11/11/2013 11:40:01 AM - Zacks.com


Data on ArQule's Tivantinib - Analyst Blog
10/4/2013 10:06:39 AM - Zacks.com


Setback for ArQule - Analyst Blog
9/4/2013 5:35:23 PM - Zacks.com